According to a new report from Intel Market Research, the global Corevedilol market was valued at USD 1.75 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 6.8% during the forecast period (2026–2034). This growth is propelled by the increasing global prevalence of cardiovascular diseases, rising geriatric population, growing awareness about...